The incremental process of bone metastasis development is initiated by establishing a premetastatic niche at distant organs created by several tumor-derived factors (CCL2, IL6, lysyl oxidase (LOX), and Dickkopf WNT signaling pathway inhibitor 1 (DKK1)) of the primary tumor. The gene discussed is LOX; the disease is neoplasm.